In previous report, EXT1 has been reported as to enhance canonical WNT signalling activity during chondrogenic differentiation,12 in addition, knock‐down of EXT1 using CRISPR/Cas9 resulted in aberrant WNT signalling in multiple myeloma.22 Here, EXT1 is linked to plasma cell myeloma.